secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLIFE SOLUTIONS INC (BLFS)
CIK:        0000834365
Form:       8-K
Filed at:   2023-07-27T23:59:59+00:00
Accession:  0001628280-23-025959
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BioLife Solutions stockholders re-elect directors, approve executive compensation and 2023 Incentive Plan
--------------------------------------------------------------------------------

- Re-elected all seven director nominees: Michael Rice, Joydeep Goswami, Joseph Schick, Amy DuRoss, Rachel Ellingson, Roderick de Greef, and Timothy Moore.
- Approved non-binding advisory vote on named executive officer compensation: 28,011,724 for, 5,972,831 against.
- Ratified appointment of Grant Thornton LLP as independent auditor for FY2023: 38,080,800 votes for.
- Approved 2023 Omnibus Performance Incentive Plan: 32,018,463 votes for, 1,961,503 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/834365/000162828023025959/0001628280-23-025959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/834365/000162828023025959/blfs-20230721.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-025959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer